Atlas Trials

Recurrent Lung Small Cell Carcinoma

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Lung Small Cell Carcinoma

RecordFirmDate
Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer (NCT04919382)Dwight Owen2022-01-26
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV (NCT04514484)National Cancer Institute (NCI)2021-11-22
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability (NCT04804644)NRG Oncology2021-06-08
Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs (NCT03896503)National Cancer Institute (NCI)2019-12-30
Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer (NCT03382561)National Cancer Institute (NCI)2018-05-21
Navitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid Tumors (NCT03366103)National Cancer Institute (NCI)2018-03-20
Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer (NCT01638546)National Cancer Institute (NCI)2012-07-27
RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer (NCT01217411)National Cancer Institute (NCI)2010-10-01
Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer (NCT00453154)National Cancer Institute (NCI)2007-03-15

Track Recurrent Lung Small Cell Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.